SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-016725
Filing Date
2020-02-11
Accepted
2020-02-11 17:05:24
Documents
3
Period of Report
2020-02-11
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm207146d1_8k.htm 8-K 17794
2 EXHIBIT 3.1 tm207146d1_ex3-1.htm EX-3.1 4219
3 GRAPHIC tm207146d1_ex3-1img01.jpg GRAPHIC 447356
  Complete submission text file 0001104659-20-016725.txt   639689
Mailing Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139 617-863-5524
INVIVO THERAPEUTICS HOLDINGS CORP. (Filer) CIK: 0001292519 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37350 | Film No.: 20597957
SIC: 3841 Surgical & Medical Instruments & Apparatus